← All Syros Pharmaceuticals, INC filings

Syros Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OTC.Pink
SYRS
Syros Pharmaceuticals, INC
DEFA14A: Syros Pharmaceuticals to Hold Annual Stockholder Meeting on June 5, 2024
Syros Pharmaceuticals announces its annual stockholder meeting to be held virtually on June 5, 2024, with several key proposals to be voted on.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
DEF 14A: Syros Pharmaceuticals Seeks Stockholder Approval for Key Proposals at 2024 Annual Meeting
Syros Pharmaceuticals is holding its 2024 annual meeting virtually on June 5, 2024, seeking stockholder approval on director elections, equity incentive plan amendments, and other corporate governance matters.